2-(3-fluorophenyl)benzo[d]isothiazol-3-one | 1220850-03-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 2-(3-fluorophenyl)benzo[d]isothiazol-3-one
• 英文别名: 2-(3-fluorophenyl)benzo[d]isothiazol-3(2H)-one；2-(3-Fluorophenyl)-1,2-benzothiazol-3-one
• CAS: 1220850-03-2
• 化学式: C₁₃H₈FNOS
• 分子量: 245.277
• InChiKey: OWKGMGZSBOHBQA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,2-二硫二苯甲酰氯 在 溴 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 12.0h， 生成 2-(3-fluorophenyl)benzo[d]isothiazol-3-one
  参考文献：
  名称：

  苯并异噻唑酮的广谱抗感染特性及其类似物的抗菌和抗真菌作用

  摘要：

  合成了各种单-和双-苯并噻吩并唑酮衍生物，并针对不同的细菌和真菌菌株进行了筛选，以了解多个亲电硫原子和活性硫紧邻区域的取代方式的影响。金黄色葡萄球菌-ATCC 7000699，MRSA和金黄色葡萄球菌-ATCC 29213（质量控制菌株）对此类化合物更敏感，而最有效的衍生物1.15的MIC 500.4μg/ mL（参见庆大霉素= 0.78μg/ mL）。CLogP值最好在2.5-3.5的范围内，它似乎对活性的贡献大于在氮上连接的基团的空间和电子效应。大体上，它们的抗真菌活性在结构和CLogP值方面也遵循相似的趋势。 N-苄基衍生物（1.7）对烟曲霉的最佳IC 50 = 0.1μg/ mL ; 它也是对强效的白色念珠菌，新型隐球菌，申克孢子丝，和近平滑念珠菌带IC 50值范围从0.4到1.3μg/ mL。初步研究还表明，这类化合物具有以低微摩尔范围的IC 50值靶向疟原虫的能力，并且可以通过结构优化来提高选择性。

  DOI：

  10.1016/j.bmcl.2017.01.027

文献信息

• An efficient copper mediated synthetic methodology for benzo[d]isothiazol-3(2H)-ones and related sulfur–nitrogen heterocycles
  作者：Bhagat Singh Bhakuni、Shah Jaimin Balkrishna、Amit Kumar、Sangit Kumar

  DOI：10.1016/j.tetlet.2012.01.003

  日期：2012.3

  A copper mediated sulfur–nitrogen coupling reaction for the synthesis of benzo[d]isothiazol-3(2H)-ones and related sulfur–nitrogen heterocycles has been presented, which requires 2-halo-arylamides, sulfur powder, 25–50 mol % of copper iodide/1,10-phenanthroline, and potassium carbonate as base.

  提出了铜介导的硫-氮偶联反应，用于合成苯并[ d ]异噻唑-3（2 H）-酮和相关的硫-氮杂环，该反应需要2-卤代芳基酰胺，硫粉，25-50摩尔％的碘化铜/ 1，10-菲咯啉和碳酸钾作为碱。
• Exploring the Structural Requirements for Inhibition of the Ubiquitin E3 Ligase Breast Cancer Associated Protein 2 (BCA2) as a Treatment for Breast Cancer
  作者：Ghali Brahemi、Fathima R. Kona、Annalisa Fiasella、Daniela Buac、Jitka Soukupová、Andrea Brancale、Angelika M. Burger、Andrew D. Westwell

  DOI：10.1021/jm901757t

  日期：2010.4.8

  The zinc-ejecting aldehyde dehydrogenase (A LDH) inhibitory drug disulfiram (DS F) was found to be a breast cancer-associated protein 2 (BCA2) inhibitor with potent antitumor activity. We herein describe our work in the synthesis and evaluation of new series of zinc-affinic molecules to explore the structural requirements for selective BCA2-inhibitory antitumor activity. An N(C=S)S-S motif was found to be required, based on selective activity in BCA2-expressing breast cancer cell lines and against recombinant BCA2 protein. Notably, the DSF analogs (3a and 3c) and dithio(peroxo)thioate compounds (5d and 5f) were found to have potent activity (submicromolar IC(50)) in BCA2 positive MCF-7 and T47D cells but were inactive (IC(50)> 10 mu M) in BCA2 negative M DA-MB-231 breast cancer cells and the normal breast epithelial cell line MCF10A. Testing in the isogenic BCA2 +ve M DA-MB-231/ER cell line restored antitumor activity for compounds that were inactive in the BCA2 -ve MDA-MB-231 cell line. In contrast, structurally related dithiocarbamates and benzisothiazolones (lacking the disulfide bond) were all inactive. Compounds 5d and 5f were additionally found to lack ALDH-inhibitory activity, suggestive of selective E3 ligase-inhibitory activity and worthy of further development.
• SMALL MOLECULE OXIDIZERS OF PDI AND THEIR USE
  申请人：THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK

  公开号：US20180092908A1

  公开（公告）日：2018-04-05

  The present invention provides a method for treating or ameliorating the effects of a neurodegenerative disorder in a subject in need thereof. The method includes, for example, administering to the subject an effective amount of a compound selected from: combinations thereof, or an N-oxide, crystalline form, hydrate thereof, or a pharmaceutically acceptable salt thereof. The present invention also provides a method for treating or ameliorating the effects of a condition associated with increased protein disulfide isomerase (PDI) activity and a method of modulating PDI activity in a cell. The present invention also provides compounds, salts, compositions and kits useful for the provided methods.
• METHODS AND USES OF PROTEIN DISULFIDE ISOMERASE INHIBITORY COMPOUNDS
  申请人：The University of Vermont and State Agricultural College

  公开号：US20210353620A1

  公开（公告）日：2021-11-18

  Compositions and methods involving protein disulfide isomerase (PDI) inhibitors, such as protein disulfide isomerase A3 (PDIA3) inhibitory compounds, for human coronavirus, such as severe acute respiratory syndrome (SARS) virus (e.g., SARS-CoV-2), therapies are disclosed herein.
• Broad spectrum anti-infective properties of benzisothiazolones and the parallels in their anti-bacterial and anti-fungal effects
  作者：P. Gopinath、R.K. Yadav、P.K. Shukla、K. Srivastava、S.K. Puri、K.M. Muraleedharan

  DOI：10.1016/j.bmcl.2017.01.027

  日期：2017.3

  were synthesized and screened against different strains of bacteria and fungi in order to understand the effect of multiple electrophilic sulfur atoms and substitution pattern in the immediate vicinity of reactive sulfur. Staphyllococcus aureus-ATCC 7000699, MRSA and S. aureus-ATCC 29213 (Quality Control strain) were more susceptible to this class of compounds, and the most potent derivative 1.15 had

  合成了各种单-和双-苯并噻吩并唑酮衍生物，并针对不同的细菌和真菌菌株进行了筛选，以了解多个亲电硫原子和活性硫紧邻区域的取代方式的影响。金黄色葡萄球菌-ATCC 7000699，MRSA和金黄色葡萄球菌-ATCC 29213（质量控制菌株）对此类化合物更敏感，而最有效的衍生物1.15的MIC 500.4μg/ mL（参见庆大霉素= 0.78μg/ mL）。CLogP值最好在2.5-3.5的范围内，它似乎对活性的贡献大于在氮上连接的基团的空间和电子效应。大体上，它们的抗真菌活性在结构和CLogP值方面也遵循相似的趋势。 N-苄基衍生物（1.7）对烟曲霉的最佳IC 50 = 0.1μg/ mL ; 它也是对强效的白色念珠菌，新型隐球菌，申克孢子丝，和近平滑念珠菌带IC 50值范围从0.4到1.3μg/ mL。初步研究还表明，这类化合物具有以低微摩尔范围的IC 50值靶向疟原虫的能力，并且可以通过结构优化来提高选择性。